Peter Haahr Email and Phone Number
Peter Haahr's Location
Copenhagen, Capital Region of Denmark, Denmark, Denmark
Peter Haahr's Contact Details
Peter Haahr work email
- Valid
- Valid
Peter Haahr personal email
n/a
About Peter Haahr
Peter Haahr is a Chief Executive Officer at LEO Foundation at LEO Fondet - LEO Foundation. He possess expertise in business strategy, change management, mergers, business planning, pharmaceutical industry and 15 more skills. He is proficient in German and English. Colleagues describe him as "Peter is a real asset for a team, hard worker, always available for support and his charisma is leading to a brillant workgroup."
Peter Haahr's Current Company Details
Peter Haahr Work Experience Details
-
Chief Executive OfficerLeo Fondet - Leo Foundation Sep 2021 - PresentCopenhagen Ø, Dk, DkThe LEO Foundation is one of Denmark’s largest commercial foundations and an engaged owner of the pharmaceutical company LEO Pharma. The Foundation’s main objective is to ensure the company’s long-term development and success as a global leader in dermatology, delivering outstanding results.Besides the ownership, the Foundation provides philanthropic grants with the aim to support the best international research in skin diseases and make Denmark a global beacon for skin research.In addition, the Foundation manages financial assets of around DKK 16bn (~ EUR 2.1bn). These assets are invested with the main objectives of ensuring the continued capability to support LEO Pharma’s long-term development and provide funds for philanthropic activities.
-
Board Member - Remuneration And Nomination Commitee, Innovation Commitee And Audit CommitteeLeo Pharma Sep 2021 - PresentBallerup, Dk, DkLEO Pharma is an independent, research-based global pharmaceutical company dedicated to advancing the standard of care for the benefit of people with skin conditions, their families and society, recording revenue of around 10 bn dkk in 2021 -
Board MemberWorld Diabetes Foundation Jan 2023 - PresentBagsværd, Capital Region, DkThe World Diabetes Foundation was founded in 2002 as an independent foundation by Novo Nordisk A/S, and today is a leading global funder of diabetes prevention and care projects in low- and middle-income countries. Over past 20 years WDF has provided USD 180m+ in funding to 575+ projects in 119 counties. -
Advisory Board MemberHc Andersen Capital Sep 2020 - PresentCopenhagen, Capital Region Of Denmark, DkHC Andersen Capital is an advisory company providing capital markets company analysis and events through a digital platform connecting Danish small cap companies and investors. -
Board Member - ChairmanHouse Of Denmark A/S Nov 2002 - PresentVejle, South Denmark, Dk -
Chair Of The BoardStockrate Asset Management Mar 2023 - Sep 2024Hillerød, DkStockRate Asset Management is a long-term, independent asset manager with around DKK 10 billion of assets under management. The company has a unique investment philosophy and strong values, like decency, transparency and responsibility, where the customers needs always are at center. -
Board Member - Deputy ChairmanNnit Mar 2017 - Mar 2022Copenhagen, Capital Region Of Denmark, DkNNIT is one of Denmark's leading consultancies in IT development, implementation and operations. NNIT's services offerings include advising, building, implementing, managing and supporting IT solutions and operating IT systems for customers. NNIT is listed on OMX NASDAQ with a market capitalization of around DKK 3bn. -
Chief Financial OfficerNovo Holdings Nov 2016 - Sep 2021Hellerup, Gentofte, DkCFO and member of Executive Management at Novo Holdings, including Chair of Investment Committee and Chair of Risk and Allocation Committee. Novo Holdings oversees, invests and manages assets valued of around USD 100 billion as per end 2021. Besides being the controlling shareholder in the Novo Group companies, including Novo Nordisk and Novozymes, Novo Holdings provides seed, venture and growth capital to development stage companies and takes significant ownership positions in well-established companies within life science, as well as manages a broad portfolio of financial assets. -
Board Member - Chairman Of Audit CommiteeSymphogen Sep 2018 - Jun 2020Ballerup, DkSymphogen is a clinical-stage antibody oncology-focused company with a differentiated product pipeline and significant commercial opportunities. The pre-clinical and clinical pipeline is well suited for a precision-medicine approach by addressing well-defined, biomarker-selected patient populations -
Member Of Advisory BoardExhalation Technology Ltd Mar 2015 - Nov 2016Exhalation Technology develops breath analysis devices for disease diagnosis, monitoring, and management. The company aim to revolutionize respiratory care by providing clinicians the tools they need to provide optimal patient care -
Cvp, Corporate DevelopmentNovo Nordisk A/S Sep 2013 - Nov 2016Bagsværd, DkHeading function of around 40 people organised into Corporate Strategy, Business Development, Alliance Management and Competitive Analysis. The function drives strategy and M&A and analyses the competitive environment for the company, as well as conducting business development deals and overseeing subsequent partnerships. -
Vp, Strategic Operations, International OperationsNovo Nordisk A/S Aug 2010 - Sep 2013Bagsværd, DkHeading a function of around 35 people in five departments Marketing & Business Development, Market Access & Commercial Effectiveness, Finance & Logistics, Business IT as well as Legal & Compliance. The function provides strategic and financial direction for emerging markets as well as a broad range of operational support and project management.
-
Director, Operations & FinanceNovo Nordisk A/S Feb 2008 - Jul 2010Bagsværd, DkHeading a function of some 40 people with 7 direct reports. Areas of direct responsibilities includes Controlling, Accounting, Order Processing, Procurement, Facility and Fleet management, Legal and IT.
-
Director, Operations & FinanceNovo Nordisk A/S Nov 2006 - Feb 2008Bagsværd, DkHeading a function of some 50 people with 7 direct reports over 3 countries. Areas of direct responsibilities includes Controlling, Accounting, Logistics (Order Processing, Procurement, Facility and Fleet management) and IT.
-
Vp, Corporate Financial PlanningNovo Nordisk A/S Nov 2004 - Nov 2006Bagsværd, DkHeading a function of about 35 people in four departments providing financial planning support and reporting for executive management and board of directors.
-
Vp, Head Of Investor RelationsNovo Nordisk A/S Oct 2000 - Oct 2004Bagsværd, DkHeading a function of 4 people located in Denmark and New Your with responsibility for the Investor Relations function, including relationship to Copenhagen and New York Stock Exchange, Stock Exchange announcements, Roadshows, Conference calls, Q&As etc.
-
Board MemberNovo Nordisk Pharmatech A/S Jul 2012 - Nov 2016Køge, DkNovo Nordisk Pharmatech is the leading worldwide supplier of products such as recombinant insulin for cell growth media and pharmaceutical grade quaternary ammonium compounds (Quats) for the pharmaceutical and personal care industries. -
Senior Equity AnalystGudme Rasschou / Panmure Gordon Oct 1998 - Oct 2000Equity analyst overseeing the Nordic Health Care Sector conducting research, roadshows etc. and amongst others participating in the listing of the Danish company Lundbeck. Job included a 1 year stay working in London City.
-
Equity AnalystBg Bank (Today Danske Bank) Jan 1997 - Oct 1998Copenhagen, Capital Region Of Denmark, DkEquity analyst responsible for research related to the Danish Health Care sector. -
Equity AnalystSydbank 1995 - 1997Aabenraa, DkEquity analyst with broad research responsibility for companies listed on the Danish stock exchange.
Peter Haahr Skills
Business Strategy
Change Management
Mergers
Business Planning
Pharmaceutical Industry
Corporate Finance
Strategic Planning
Due Diligence
Financial Analysis
Strategy
Forecasting
Restructuring
Managerial Finance
Business Development
Risk Management
Valuation
Management
Sales Effectiveness
Management Consulting
Financial Modeling
Peter Haahr Education Details
-
ImdRole Of The Chair -
ImdHigh Performance Boards
-
Stanford UniversityDirectors' Consortium
-
ImdLeadership
-
Aarhus UniversityFinance And Accounting
Frequently Asked Questions about Peter Haahr
What company does Peter Haahr work for?
Peter Haahr works for Leo Fondet - Leo Foundation
What is Peter Haahr's role at the current company?
Peter Haahr's current role is Chief Executive Officer at LEO Foundation.
What is Peter Haahr's email address?
Peter Haahr's email address is pe****@****novo.dk
What schools did Peter Haahr attend?
Peter Haahr attended Imd, Imd, Stanford University, Imd, Aarhus University.
What skills is Peter Haahr known for?
Peter Haahr has skills like Business Strategy, Change Management, Mergers, Business Planning, Pharmaceutical Industry, Corporate Finance, Strategic Planning, Due Diligence, Financial Analysis, Strategy, Forecasting, Restructuring.
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial